Clover Corporation Ltd
Clover Corporation Limited focused on technology, new product development, and commercialization.
The business
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Small Caps Research
No research on Clover Corporation Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise CLV based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
Clover Corporation Posts Strong 1H FY26 Results with Maintained FY26 Guidance
Clover Corporation: 1H FY26 revenue up 17% to $44.1m, gross margin 35.6%; FY26 guidance $92-96m kept, signaling stronger 2H FY26.
Clover Corporation Positions for Continued Growth Following Solid FY25 Performance
High-value nutritional solutions manufacturer Clover Corporation (ASX: CLV) has reported a turnaround in performance for FY2025, underpinned by expansion in Europe and Asia across the nutraceutical, food & beverage, and infant formula sectors. The company recorded a 38% boost in revenue to $48.4 million from $37.6m in the previous corresponding period, while net sales revenue […]
Clover ups revenue on the back of greater infant-formula market stability in China
Baby-formula nutritional oils encapsulater Clover Corporation (ASX: CLV) has increased half-year revenue 60 per cent to $31 million and half-year net profit after tax 209 per cent to $3.2 million after greater regulatory stability was experienced in China, increasing demand. The company, which markets its oils under the NuMega Ingredients brand, increased its financial year […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.